caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1649294166

James FesenmeierMD

NephrologyAvon, INI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where James Fesenmeier's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 17 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
INDIANA UNIVERSITY HEALTH WEST HOSPITAL INC237794
INDIANA UNIVERSITY HEALTH INC73195
Atul Agarwal
Diagnostic Radiology · Indianapolis, IN
2968
Joseph Lee
Hospitalist · Avon, IN
20139
Sadia Saba
Neurology · Avon, IN
2058
Brent Huffman
Neurology · Saint Louis, MO
1962
Margaret Hollar
Diagnostic Radiology · Indianapolis, IN
1746
Jeffrey Farmer
Hospitalist · Indianapolis, IN
17122
Bhaskar David Bose
Geriatric Medicine · Indianapolis, IN
1679
Damon Davis
Hospitalist · Indianapolis, IN
1640
Laura Barnett
Internal Medicine · Indianapolis, IN
15137
Anjan Sinha
Cardiology · Indianapolis, IN
1436
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
415
Unique beneficiaries
—
Total services
7,763
Distinct HCPCS
11
Medicare payment
$74K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 192 Nephrology providers in IN — top quintile (cohort median 1,421).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,777
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
62
Brand share
30.0%
Top prescribed drugs
Gabapentin228 claims
Carbidopa/Levodopa190 claims
Clonazepam139 claims
Levetiracetam117 claims
Donepezil Hcl100 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$18
Payment records
1
By payment type
Education$18